Elena Shklovskaya

5PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 11, 2026
Prednisolone modulates CD8⁺ and regulatory T-cell activity to dampen response to immune checkpoint inhibitor therapy in melanoma.

Jesse R Brown, Bernadette Pedersen, Georgina V Long

|Feb 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan

|Jun 16, 2023
SERS characterization of colorectal cancer cell surface markers upon anti-EGFR treatment.

Nana Lyu, Bernadette Pedersen, Elena Shklovskaya

|Mar 19, 2023
The molecular and functional landscape of resistance to immune checkpoint blockade in melanoma.

Su Yin Lim, Elena Shklovskaya, Jenny H Lee

|Feb 15, 2023
Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.

Hansol Lee, Angela L Ferguson, Camelia Quek

Pageof 1

Frequent Collaborators

5 joint publications

Helen Rizos

4 joint publications

Georgina V Long

3 joint publications

Richard A Scolyer

2 joint publications

Camelia Quek